Landec Corp expected to post a loss of 13 cents a share - Earnings Preview

Lifecore Biomedical

04/10/2022 13:32

* Landec Corp  LNDC.OQ   LNDC.O  is expected to show a fall
in
quarterly revenue when it reports  results on October 6. 
    * The Santa Maria California-based  company is expected to
report 
a 66.8% decrease in revenue to $42.738 million from $128.79
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Landec Corp is for
a loss
of 13 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Landec Corp
is
$14​, above​ its last closing price of $9.08. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 May. 31 2022              -0.01      -0.01     Met     25
 Feb. 28 2022  -0.01       0.00       -0.08     Missed  -1,500
 Nov. 30 2021  -0.04       -0.04      0.05      Beat    225​
 Aug. 31 2021  -0.12       -0.12      -0.23     Missed  -98.3
 ​​May.        -0.01       -0.01      0.07      Beat    975
 31 2021                                                
 Feb. 28 2021  0.03        0.02       -0.09     Missed  -475​
 Nov. 30 2020  0.03        0.01       0.02      Beat    100
 Aug. 31 2020  -0.12       -0.11      -0.11     Met     0
 This summary was machine generated October 4 at 12:32 GMT.  All
figures in US dollars  unless otherwise stated